AMZN
Amazon.com, Inc.
AMZN has the edge over JRSH overall, supported by stronger valuation.
JRSH
Jerash Holdings (US), Inc.
JRSH has slightly lower modeled downside risk, despite its lower overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
JRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
JRSH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over JRSH in the historical PE scenario, which offers more potential upside but is not a forecast.
JRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $4.11 | -44% |
| Fair | 14x | $6.75 | -8.1% |
| Current | 15x | $7.35 | — |
| Forward | 15x | $7.35 | — |
| Expensive | 26x | $12.70 | +73% |
Historical ranges are pointers, not guarantees.
JRSH's PE is in its fair range at 15.0x. On analysts' estimates for next year's earnings, today's price would be 15.2x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
JRSH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
JRSH has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over JRSH on earnings, with more consistent year-over-year improvement.
JRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.49 | -1% |
| Q3 2026 | $0.49 | +717% |
| Q2 2026 | $0.37 | +429% |
| Q1 2026 | $0.27 | +$0.34 |
| Q4 2025 | $0.15 | +$0.46 |
| Q3 2025 | $0.06 | +$0.35 |
| Q2 2025 | $0.07 | +$0.38 |
| Q1 2025 | -$0.07 | +$0.09 |
| Q4 2024 | -$0.31 | -$0.24 |
JRSH's earnings per share have fallen from their peak: $0.49 over the past year, against $0.75 in late 2021.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over JRSH on profitability, with a higher operating margin.
JRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.3M | +20% |
| Q2 2026 | $50.2M | +27% |
| Q1 2026 | $42.9M | +47% |
| Q4 2025 | $41.8M | +18% |
| Q3 2025 | $42M | +4.3% |
| Q2 2025 | $39.6M | -3.2% |
| Q1 2025 | $29.3M | +36% |
| Q4 2024 | $35.4M | +29% |
JRSH's revenue has grown year over year for five quarters in a row: $50M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.1% | +3.5 points |
| Q2 2026 | 5.2% | +2.8 points |
| Q1 2026 | 5.5% | +4 points |
| Q4 2025 | 4.7% | +2.7 points |
| Q3 2025 | 2.6% | -0.2 points |
| Q2 2025 | 2.4% | +4.4 points |
| Q1 2025 | 1.5% | +16 points |
| Q4 2024 | 2% | +0.6 points |
JRSH's operating margin was 6.1% last quarter, up 3.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
JRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4M | -32% |
| Q2 2026 | $2.3M | +$9.3M |
| Q1 2026 | $1.8M | +21% |
| Q4 2025 | -$3.9M | -$750.5K |
| Q3 2025 | $6.4M | +46% |
| Q2 2025 | -$6.9M | -$4.6M |
| Q1 2025 | $1.5M | +$7.3M |
| Q4 2024 | -$3.2M | -$2.7M |
JRSH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over JRSH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
JRSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +113K shares |
| 1 year | +2.5% | +326K shares |
| 3 years | +9.8% | +1.2M shares |
| 5 years | +17% | +2M shares |
| Available history | +18% | +2.1M shares |
JRSH has 14M diluted shares, up 2.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | $397,152 |
| Q4 2022 | $224,181 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
JRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -4.6x | Net Cash |
| Q4 2024 | -13.3x | Net Cash |
JRSH has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
JRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 84.7 | Overbought |
| Stochastic | 74.8 | Neutral |
JRSH's weekly RSI is 85 (overbought) and its Stochastic is 75 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
JRSH PE vs Consumer Cyclical Sector
| Metric | JRSH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 17% below |
| PE % | 58 | 47 | 11 pts above |
JRSH has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
JRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.21 | 18% above |
| 20 week MA | $5.50 | 34% above |
| 50 week MA | $4.16 | 77% above |
| 100 week MA | $3.75 | 96% above |
| 200 week MA | $3.60 | 104% above |
JRSH is in an uptrend: it's above all five of its weekly moving averages, and 104% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
JRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.02 | $5.52 | -8.3% |
| 2021 | $5.52 | $6.70 | +21% |
| 2022 | $6.70 | $4.03 | -40% |
| 2023 | $4.03 | $3.11 | -23% |
| 2024 | $3.11 | $3.43 | +10% |
| 2025 | $3.43 | $3.03 | -12% |
| 2026 YTD | $3.03 | $7.35 | +143% |
JRSH has the edge over AMZN on returns for 2026, with the stronger performance.